Saturday, 7 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Bal Pharma Merger & Restructuring

Bal Pharma is incorporating a new Joint Venture in the Philippines to distribute pharmaceutical products. The company will hold a 65% equity stake in this entity.

Source

NSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bal Pharma Ltd: key numbers

Share price
₹81.55
Market cap
₹129.8 Cr
Revenue (annual)
₹311.7 Cr
Net profit (annual)
₹6.28 Cr
P/E (TTM)
18.0×Sector 43.0×
Promoter holding
50.86%+0.00% QoQ
FII holding
0.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bal Pharma Ltd

All →

Other merger & restructuring announcements

All →